Onderneming Crescita Therapeutics Inc. Other OTC
Aandelen
CRRTF
CA2258471028
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Commercial Skincare
59,6
%
| 8 | 34,1 % | 10 | 59,6 % | +30,14% |
Manufacturing and Services
28,8
%
| 14 | 58,2 % | 5 | 28,8 % | -63,13% |
Licensing and Royalties
11,6
%
| 2 | 7,7 % | 2 | 11,6 % | +12,78% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
66,9
%
| 10 | 41,6 % | 12 | 66,9 % | +19,74% |
United States
23,8
%
| 12 | 51,6 % | 4 | 23,8 % | -65,58% |
Rest-of-World
9,2
%
| 2 | 6,8 % | 2 | 9,2 % | +1,38% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Serge Verreault
CEO | Chief Executive Officer | - | - |
Jose DaRocha
DFI | Director of Finance/CFO | - | 01-09-17 |
Daniel Chicoine
CHM | Chairman | 70 | 01-03-16 |
Wade Hull
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-16 |
Linda Kisa
IRC | Investor Relations Contact | - | - |
Ramirez Medina
PRN | Corporate Officer/Principal | - | 01-06-21 |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 01-03-16 | |
Daniel Chicoine
CHM | Chairman | 70 | 01-03-16 |
John London
BRD | Director/Board Member | - | 01-03-16 |
Deborah Trudeau
BRD | Director/Board Member | - | 10-11-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 19 541 391 | 17 448 741 ( 89,29 %) | 0 | 89,29 % |
Bedrijfsgegevens
Crescita Therapeutics, Inc.
2805 Place Louis-R Renaud
H7V 0A3, Laval
+
http://www.crescitatherapeutics.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+34,35% | 693 mld. | |
+29,39% | 584 mld. | |
-3,49% | 372 mld. | |
+20,15% | 332 mld. | |
+6,19% | 294 mld. | |
+14,11% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+9,21% | 168 mld. |